SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics ($CAPR) is trending due to positive Phase 3 trial results for its DMD treatment, deramiocel, sparking optimism for FDA approval. The stock saw a massive surge, leading to discussions about potential short squeezes and long-term value, with some community members predicting prices well beyond current levels. Bullish sentiment is fueled by the potential for buyout offers and the prospect of deramiocel becoming a significant treatment option, though some caution against short-term volatility.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd is actively chanting the ticker $CAW and expressing excitement, referring to themselves as a strong, organic community. The token's multichain functionality and deflationary burn mechanism are key talking points, with some suggesting it is the leading meme coin on the Cronos chain.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential following recent earnings and its position in the automation and AI space, with some highlighting its profitability and partnerships. Community members are debating whether the company is undervalued compared to its peers, while others are analyzing its growth trajectory and market adoption. Discussions also include the impact of potential short squeezes and the company's long-term prospects within the evolving AI landscape.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as community members discuss the potential impact of Marvell's acquisition of Celestial AI, a key partner utilizing POET's optical interposer technology. Community members speculate on potential increased demand and a possible acquisition, with many viewing the recent price action as an opportunity. Some believe the acquisition validates POET's technology and could lead to significant growth in the AI interconnect market.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses potential breakouts and its established role as 'digital silver'. The conversation highlights its reliable payment network and the possibility of a Litecoin ETF, sparking interest in its utility and long-term potential. Some users are also closely watching the LTCBTC chart for bullish signals.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to significant price movement and high trading volume, sparking discussions about potential short squeezes and the company's fundamentals. Community chatter includes both bullish speculation for continued upward momentum and bearish concerns regarding possible dilution and reverse splits. The stock's volatile behavior is drawing attention, with some comparing it to other high-flying tickers.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as investors react to earnings and a new partnership with Palantir, focusing on AI-driven cloud solutions. The community is debating whether the earnings justify the valuation and discussing the potential impact of the Palantir collaboration on the company's growth trajectory. SNOW's performance is also being compared to competitors in the data and AI space, such as Databricks and Microsoft.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

AI's stock is trending amid discussions around its recent earnings and future prospects, with some traders pointing to its high short interest as a potential catalyst for a meme-driven rally. Community sentiment is mixed, with debates focusing on the company's turnaround potential under its new CEO and its positioning within the competitive AI landscape. Some investors are closely watching for potential government contracts, as well as any partnership developments.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending amid discussions about the FTC's requirements for the Spirit AeroSystems acquisition, with the community weighing the implications for the merger and Boeing's competitive position. Some traders are focusing on technical levels and potential short squeezes, while others are discussing delivery numbers and future cash flow projections. Overall, sentiment is mixed as investors digest the news and anticipate future developments.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending as the community anticipates the Fusaka upgrade, which aims to improve scalability and lower Layer 2 transaction costs.  Enthusiasm is building around the potential for increased efficiency and broader adoption, with some expecting a significant price surge. Discussions also highlight Ethereum's potential to outperform Bitcoin and the influx of institutional investments.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Swiss National Bank Cuts Stock Holdings in Revolution Medicines, Inc. $RVMD

Swiss National Bank cut its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 3.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Revolution Medicines, Inc. $RVMD Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. cut its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 23.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange...

XTX Topco Ltd Grows Position in Revolution Medicines, Inc. $RVMD

XTX Topco Ltd lifted its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 47.6% in the second quarter, according to the company in its most recent disclosure with the...

Universal Beteiligungs und Servicegesellschaft mbH Buys 5,060 Shares of Revolution Medicines, Inc. $RVMD

Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 7.6% during the second quarter, according to the company in its...

Revolution Medicines (NASDAQ:RVMD) Reaches New 52-Week High - Here's What Happened

Revolution Medicines (NASDAQ:RVMD) Hits New 1-Year High - What's Next...

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) have received a consensus recommendation of "Buy" from the eighteen research firms that are currently covering the company...

Westfield Capital Management Co. LP Increases Holdings in Revolution Medicines, Inc. $RVMD

Westfield Capital Management Co. LP raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 55.0% in the 2nd quarter, according to the company in its most recent...

Neo Ivy Capital Management Invests $1.14 Million in Revolution Medicines, Inc. $RVMD

Neo Ivy Capital Management bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The...

Mark Goldsmith Sells 20,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark Goldsmith sold 20,000 shares of Revolution Medicines stock in a transaction on Tuesday, November 18th. The stock was sold at an...

Revolution Medicines (NASDAQ:RVMD) Upgraded at Wolfe Research

Wolfe Research upgraded shares of Revolution Medicines to a "strong-buy" rating in a report on Monday...

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

RVMD
Revolution Medicines Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RVMD News

RVMDRevolution Medicines Inc